- Home
- XERS vs FUBO Comparison
XERS vs FUBO Comparison
Compare XERS & FUBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- FUBO
- Stock Information
- Founded
- XERS 2005
- FUBO 2009
- Country
- XERS United States
- FUBO United States
- Employees
- XERS N/A
- FUBO N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- FUBO Broadcasting
- Sector
- XERS Health Care
- FUBO Industrials
- Exchange
- XERS Nasdaq
- FUBO Nasdaq
- Market Cap
- XERS 1.3B
- FUBO 1.4B
- IPO Year
- XERS 2018
- FUBO 2020
- Fundamental
- Price
- XERS $8.33
- FUBO $3.88
- Analyst Decision
- XERS Strong Buy
- FUBO Buy
- Analyst Count
- XERS 7
- FUBO 4
- Target Price
- XERS $8.00
- FUBO $5.35
- AVG Volume (30 Days)
- XERS 2.1M
- FUBO 12.8M
- Earning Date
- XERS 11-07-2025
- FUBO 10-31-2025
- Dividend Yield
- XERS N/A
- FUBO N/A
- EPS Growth
- XERS N/A
- FUBO N/A
- EPS
- XERS N/A
- FUBO 0.26
- Revenue
- XERS $246,025,000.00
- FUBO $1,625,738,000.00
- Revenue This Year
- XERS $43.89
- FUBO N/A
- Revenue Next Year
- XERS $20.40
- FUBO $6.48
- P/E Ratio
- XERS N/A
- FUBO $14.80
- Revenue Growth
- XERS 35.62
- FUBO 6.65
- 52 Week Low
- XERS $2.73
- FUBO $1.21
- 52 Week High
- XERS $8.51
- FUBO $6.45
- Technical
- Relative Strength Index (RSI)
- XERS 61.63
- FUBO 45.58
- Support Level
- XERS $7.88
- FUBO $3.75
- Resistance Level
- XERS $8.51
- FUBO $4.08
- Average True Range (ATR)
- XERS 0.37
- FUBO 0.24
- MACD
- XERS -0.01
- FUBO -0.06
- Stochastic Oscillator
- XERS 83.05
- FUBO 15.98
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About FUBO fuboTV Inc.
FuboTV Inc is a sports-first, live TV streaming company offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, FuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. It offers subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality suited to their preferences. The company has one operating segment, the streaming business. Geographically, the company generates a majority of its revenue from the United States and also has a presence in other markets.